{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000332.4:c.162A>T",
          "cDNA Change": {
            "transcript": "NM_000332.4",
            "ref": "A",
            "alt": "T",
            "position": "162"
          },
          "Protein Change": {
            "ref": "S",
            "alt": "I",
            "position": "54"
          },
          "Description in input context": "A53T"
        },
        {
          "HGVS": "NM_000332.4:c.90C>G",
          "cDNA Change": {
            "transcript": "NM_000332.4",
            "ref": "C",
            "alt": "G",
            "position": "90"
          },
          "Protein Change": {
            "ref": "P",
            "alt": "A",
            "position": "30"
          },
          "Description in input context": "A30P"
        },
        {
          "HGVS": "NM_000332.4:c.138G>A",
          "cDNA Change": {
            "transcript": "NM_000332.4",
            "ref": "G",
            "alt": "A",
            "position": "138"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "E46K"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson disease",
    "MONDO": "MONDO:0007679"
  },
  "Experiment Method": [
    {
      "Assay Method": "In vitro aggregation assays",
      "Material used": {
        "Material Source": "Recombinant protein",
        "Material Name": "alpha-synuclein",
        "Description": "Recombinant alpha-synuclein was used to examine its aggregation properties."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000332.4:c.162A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Promotes aggregation",
          "Result Description": "Recombinant A53T alpha-synuclein aggregates to form amyloid fibrils resembling Lewy bodies."
        },
        {
          "Variant": "NM_000332.4:c.90C>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Promotes aggregation",
          "Result Description": "Recombinant A30P alpha-synuclein aggregates to form amyloid fibrils resembling Lewy bodies."
        },
        {
          "Variant": "NM_000332.4:c.138G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Promotes aggregation",
          "Result Description": "Recombinant E46K alpha-synuclein aggregates to form amyloid fibrils resembling Lewy bodies."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N/A",
        "Description": "Not specified in the text."
      },
      "Technical replicates": {
        "Technical replicates": "N/A",
        "Description": "Not specified in the text."
      },
      "Basic positive control": {
        "Basic positive control": "N/A",
        "Description": "Not specified in the text."
      },
      "Basic negative control": {
        "Basic negative control": "N/A",
        "Description": "Not specified in the text."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N/A",
        "Counts": "N/A"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N/A",
        "Counts": "N/A"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not specified in the text."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N/A",
        "Source": "N/A"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N/A",
        "Source": "N/A"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}